November 13, 2026 at 11:08 AM UTC
NEKTAR THERAPEUTICS issues Regulation FD disclosure
NEKTAR THERAPEUTICS filed an 8-K covering a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 13, 2026 at 11:02 AM UTC
Open official source